Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dose-Escalation Study of Artesunate Patients With IPF — Stella

Home/Idiopathic Pulmonary Fibrosis/Dose-Escalation Study of Artesunate Patients With IPF

View on ClinicalTrials.gov

Recruiting

Back to Idiopathic Pulmonary Fibrosis trials

Dose-Escalation Study of Artesunate Patients With IPF

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Stanford University, Stanford, California

Key details

Phase

Early testing

Sponsor

Joseph C. Wu

Enrollment target

~15 participants

Started

January 2027

Primary completion

November 2027

Age range

40 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.